Medication info

Elbus Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletSucralfate Hydrate›300mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
White round film-coated tablet
Packaging
500 tablets/bottle, 30 tablets/bottle
Approval status
Expired

MFDS item code 201403960 · Approved 2014.08.25

This product's status changed to Expired on 2024.08.25. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers and gastritis); prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
○ Adults Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, with or without food. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher treatment rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for concomitant treatment to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medication, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 2 tablets twice daily or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily and increase the dose if necessary. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers and gastritis); prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by NSAIDs.
View approved original text

This medication is used to treat gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson's syndrome before anesthesia and helps prevent ulcers that may occur post-surgery. It is effective in treating gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It acts effectively on various gastrointestinal diseases to improve symptoms.

How to take

Adult dose

○ Adults Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, with or without food. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher treatment rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for concomitant treatment to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, the healing period may occasionally be prolonged in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medication, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 2 tablets twice daily or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets 4 times daily. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily and increase the dose if necessary. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and give 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Precautions

This medication should not be administered to patients undergoing dialysis or those with allergies to this drug or its ingredients. Patients with a history of acute porphyria should also not use this drug, nor should it be administered to patients with renal impairment, those who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants or newborns, and patients on a restricted potassium diet. Use with caution in patients with liver dysfunction or a history of drug allergies, the elderly, and those with a history of renal impairment. If taking NSAIDs, especially elderly patients or those with a history of peptic ulcers should undergo regular check-ups. This drug can mask symptoms of gastric cancer, so patients over middle age with gastric ulcers or new or changing dyspeptic symptoms should confirm malignancy before treatment. Helicobacter pylori-positive gastric and duodenal ulcer patients require eradication therapy. Severe patients in intensive care may develop bezoars after administration of this drug, so caution is needed, and patients with low phosphate levels may experience impaired absorption of phosphorus due to the aluminum component in this drug. Patients who have difficulty swallowing should be cautious as this drug may lead to respiratory complications after ingestion. This drug can rarely cause severe allergic reactions or shock; if unusual symptoms occur during administration, it should be discontinued immediately, and healthcare professionals should be consulted. Symptoms of hypersensitivity such as skin rash, urticaria, angioedema, fever, and respiratory distress may occur, and use should be stopped if such symptoms arise. Blood tests may show decreases in white blood cells and platelets or liver function abnormalities, and if symptoms appear, immediate consultation with a physician is advised. Abnormalities in heart rhythm, gastrointestinal symptoms, dizziness, drowsiness, mental confusion, headaches, and other neurological symptoms may also occur rarely necessitating caution. Long-term use should be avoided, and during treatment, symptoms along with blood, liver, and kidney functions should be periodically monitored. Elderly patients or those with chronic lung diseases or diabetes may have a higher risk of developing pneumonia while using this drug. If dizziness or drowsiness occurs after taking this medication, avoid driving or operating hazardous machinery. This drug may interact with other medications, so if other drugs are being taken, it is essential to inform healthcare professionals. Especially when used in conjunction with anticoagulants or certain antibiotics and anticonvulsants, dose adjustment may be necessary. Pregnant or breastfeeding women are advised against using this medication. Safety in children has not been fully established, so its use is not recommended. This drug may affect some clinical test results, so inform healthcare professionals about its use during testing. In the event of overdose, emergency treatment such as vomiting or gastric lavage may be necessary, and blood dialysis may be required for removal if necessary. This drug reduces gastric acid secretion, which may lead to an increase in bacterial growth in the gastrointestinal tract, so regular check-ups including eye examinations are necessary during prolonged use.

Side effects

  • anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 58 more
  • thrombocytopenia
  • serum enzyme elevation
  • agranulocytosis
  • hypoproliferative anemia
  • aplastic anemia
  • aplastic anemia
  • hypoplastic anemia
  • acquired autoimmune hemolytic anemia
  • eosinophilia
  • AST elevation
  • ALT elevation
  • r-GTP elevation
  • ALP elevation
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • decreased appetite
  • dizziness
  • drowsiness
  • confusional state
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • illness perception
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disturbance
  • generalized myoclonus
  • gynecomastia
  • hypersecretion of milk
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • alopecia
  • stomatitis
  • skin itching
  • skin-mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container to prevent air exposure, and it is advisable to keep it at room temperature between 1 degree and 30 degrees Celsius. This storage method helps maintain the drug's efficacy and prevent degradation.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

500 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.